Pulsatile perfusion preservation for expanded-criteria donors kidneys: Impact on delayed graft function rate

Int J Artif Organs. 2011 Jun;34(6):513-8. doi: 10.5301/IJAO.2011.8458.

Abstract

Purpose: Expanded criteria donors (ECD) kidneys are a potential solution to organ shortage, but exhibit more delayed graft function (DGF). We conducted a prospective controlled study aiming to evaluate the impact of pulsatile perfusion preservation (PPP) on DGF rate.

Methods: Inclusion criteria were: 1) ECD definition (any brain-dead donor aged > 60 years or aged 50-60 years with at least 2 of the following: history of hypertension, terminal serum creatinin level = 1.5 mg/dL, death resulting from a cerebrovascular accident; 2) Donor prolonged circulatory arrest (> 20 mn); 3) previsible cold ischemia time longer than 24 hours. In each pair of kidneys, one organ was preserved with PPP and the other organ was preserved in static cold storage.

Results: From February 2007 to September 2009, a total of 22 donors (44 recipients) were included. Recipients were comparable in the two groups with respect to demographic and immunological data. The rate of DGF was significantly lower (9% vs. 31.8%, p = 0.021) in the PPP group. At 1, 3, and 12 months, renal function was comparable in the two groups.

Conclusions: Pulsatile perfusion preservation significantly reduced DGF rate in ECD kidney transplantation.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Cold Ischemia
  • Cold Temperature
  • Delayed Graft Function / etiology
  • Delayed Graft Function / prevention & control*
  • Female
  • France
  • Graft Survival
  • Humans
  • Kidney Transplantation* / adverse effects
  • Kidney Transplantation* / mortality
  • Male
  • Middle Aged
  • Organ Preservation / adverse effects
  • Organ Preservation / methods*
  • Organ Preservation / mortality
  • Organ Preservation Solutions
  • Perfusion* / adverse effects
  • Perfusion* / mortality
  • Prospective Studies
  • Pulsatile Flow
  • Time Factors
  • Tissue Donors / supply & distribution*
  • Treatment Outcome

Substances

  • Organ Preservation Solutions